CATALYST PHARMACEUTICALS, INC.

CPRX US14888U1016

🆔
Registration No.
4193720
💰
Capitalization
Mid-cap

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

🏢
Founded
2006
🔗
Website
Annual Performance 1
2021 2022 2023 2024 2025
92% 169% -7% 22% 0%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
60
🙍
Insiders
10
Person Price Shares Total Published Completed
Elsbernd Brian
SR OFF 		20.30
USD 		30,000
Sold 		609,000
USD 		08/09/2025 08/09/2025
Elsbernd Brian
SR OFF 		19.52
USD 		30,000
Sold 		585,600
USD 		03/09/2025 04/09/2025
Elsbernd Brian
SR OFF 		20.08
USD 		20,000
Sold 		401,600
USD 		03/09/2025 03/09/2025
Tierney David S
O 		20.20
USD 		26,000
Sold 		525,200
USD 		27/08/2025 27/08/2025
Miller Steve
SR OFF 		20.28
USD 		115,000
Sold 		2,332,200
USD 		26/08/2025 26/08/2025
Daly Richard J
CEO 		20.62
USD 		22,970
Sold 		473,641
USD 		26/08/2025 26/08/2025
Sundaram Preethi
SR OFF 		26.42
USD 		1,600
Sold 		42,272
USD 		10/06/2025 11/06/2025
Sundaram Preethi
SR OFF 		26.41
USD 		2,324
Sold 		61,377
USD 		10/06/2025 10/06/2025
Mcenany Patrick J
O 		26.11
USD 		171,748
Sold 		4,484,340
USD 		06/06/2025 09/06/2025
Mcenany Patrick J
O 		26.11
USD 		171,748
Sold 		4,484,340
USD 		06/06/2025 09/06/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include CATALYST PHARMACEUTICALS, INC. to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
2% 22% 34% 64% 361% 683% 828%
Last 52W Low 52W High All-Time Low All-Time High β
20.82 19.13 26.31 19.13 26.31
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Mcenany Patrick J 13 32,296,097.12 2,484,315.16 11/11/2024 09/06/2025
Ingenito Gary 12 21,322,065.96 1,776,838.83 06/12/2023 14/05/2025
Miller Steve 6 7,051,050.00 1,175,175.00 05/12/2023 26/08/2025
Elsbernd Brian 8 3,740,836.36 467,604.54 27/03/2024 08/09/2025
Daly Richard J 3 2,490,576.32 830,192.11 04/06/2024 26/08/2025
Tierney David S 4 1,884,905.00 471,226.25 12/12/2023 27/08/2025
Del Carmen Jeffrey 4 1,481,875.86 370,468.97 07/06/2024 03/03/2025
Grande Alicia 4 1,396,780.00 349,195.00 08/12/2023 11/12/2023
Harper Molly 4 673,369.23 168,342.31 15/12/2023 27/11/2024
Sundaram Preethi 2 103,648.84 51,824.42 10/06/2025 11/06/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.